In Vivo Shuttle LNP Skin-Targeted Kit

In Vivo Shuttle LNP series of in vivo delivery kits are developed based on a proprietary lipid nanoparticles (LNP) technology. They are systematically designed to meet diverse in vivo nucleic acid application requirements, featuring high delivery efficiency, precise targeting, and good biocompatibility. The product platform covers the entire path layout from broad-spectrum delivery to organ and cell-specific delivery, including both universal delivery solutions suitable for various nucleic acid types and delivery schemes that can precisely target important organs such as the liver, spleen, lungs, and skin, supporting organ-specific research and therapeutic development. In response to the needs of immunotherapy and vaccine research, the series has further expanded into the field of immune cell targeting, enabling effective delivery to key immune populations such as macrophages, dendritic cells, and T cells in the body, enhancing the efficacy of immune intervention. At the same time, with the rapid development of gene editing technology, the series has specially set up a gene editing tool kit, optimizing the delivery of the CRISPR/Cas9 system (Cas9 mRNA + gRNA), to help achieve efficient and precise gene function modification in the body. The in vivo nucleic acid delivery kit series adopts a standardized and modular design concept, covering the entire chain of application from universal delivery to precise treatment, and is widely applicable to gene therapy, vaccine development, functional genomics, and innovative therapy exploration, providing strong technical support for nucleic acid drug research and transformation.

Please contact us at for specific academic pricing.